ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

EVGN Evogene Ltd

0.6498
-0.0197 (-2.94%)
Last Updated: 11:29:17
Delayed by 15 minutes

Period:

Draw Mode:

Volume 20,403
Bid Price 0.641
Ask Price 0.679
News -
Day High 0.679

Low
0.4502

52 Week Range

High
1.44

Day Low 0.64
Company Name Stock Ticker Symbol Market Type
Evogene Ltd EVGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0197 -2.94% 0.6498 11:29:17
Open Price Low Price High Price Close Price Prev Close
0.65 0.64 0.679 0.6695
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
66 20,403 $ 0.6523041 $ 13,309 - 0.4502 - 1.44
Last Trade Time Type Quantity Stock Price Currency
11:29:16 100 $ 0.6498 USD

Evogene Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
32.86M 50.55M - 5.64M -23.88M -0.47 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Evogene News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No EVGN Message Board. Create One! See More Posts on EVGN Message Board See More Message Board Posts

Historical EVGN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.680.68760.6120.639668855,702-0.0302-4.44%
1 Month0.72820.86110.6120.729388972,254-0.0784-10.77%
3 Months0.76921.040.6120.8601248164,188-0.1194-15.52%
6 Months0.4771.040.46760.8121397158,9260.172836.23%
1 Year0.5851.440.45020.9019993196,9040.064811.08%
3 Years4.234.75850.45021.75218,738-3.58-84.64%
5 Years2.2610.23860.45023.56332,042-1.61-71.25%

Evogene Description

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment.

Your Recent History

Delayed Upgrade Clock